Clinical trial
Phase II Trial of SK3530 in Erectile Dysfunction
NCT00351065 · SK Chemicals Co., Ltd., Industry · Terminated
Key facts
| NCT number | NCT00351065 |
|---|---|
| Title | Phase II Trial of SK3530 in Erectile Dysfunction |
| Official title | an 8week, Multi-Center, Randomized, Double Blind, Placebo-Controlled,Parallel Group, Fixed Dose, Dose-Finding Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction. |
| Lead sponsor | SK Chemicals Co., Ltd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Male Erectile Dysfunction |
| Intervention type | Drug |
| Interventions | SK3530 |
| Enrollment | 120 |
| Start date | Sep 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Jul 12, 2006 |
| Last update posted | Jul 12, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: